MIM
Monashee Investment Management Portfolio holdings
AUM
$190M
This Quarter Return
+7.36%
1 Year Return
+42.84%
3 Year Return
+185.9%
5 Year Return
+237.5%
10 Year Return
+2,730.86%
AUM
$362M
AUM Growth
+$362M
(+56%)
Cap. Flow
+$107M
Cap. Flow
% of AUM
29.55%
Top 10 Holdings %
Top 10 Hldgs %
69.22%
Holding
74
New
28
Increased
4
Reduced
7
Closed
16
Top Buys
| 1 |
Vanguard Total Stock Market ETF
VTI
|
$92.9M |
| 2 |
iShares Russell 2000 ETF
IWM
|
$16.9M |
| 3 |
Invesco QQQ Trust
QQQ
|
$10.3M |
| 4 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$5.18M |
| 5 |
Viking Therapeutics
VKTX
|
$5M |
Top Sells
Sector Composition
| 1 | Healthcare | 14.5% |
| 2 | Technology | 3.17% |
| 3 | Industrials | 2.43% |
| 4 | Consumer Discretionary | 1.37% |
| 5 | Energy | 1.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Vanguard Total Stock Market ETF
VTI
$526B
| $156M | 43.11% | 765,000 +455,000 | +147% | +$92.9M |
|
|
2
Invesco QQQ Trust
QQQ
$364B
| $18.3M | 5.05% | 57,000 +32,000 | +128% | +$10.3M |
|
|
3
iShares Russell 2000 ETF
IWM
$67B
| $16.9M | 4.68% | +95,000 | New | +$16.9M |
|
4
Alight
ALIT
$2.05B
| $8.75M | 2.42% | 950,000 -29,397 | -3% | -$271K |
|
5
Compass Therapeutics
CMPX
$483M
| $7.12M | 1.97% | 2,177,042 -53,399 | -2% | -$175K |
|
|
KRTX
6
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $5.18M | 1.43% | +28,500 | New | +$5.18M |
|
|
7
Viking Therapeutics
VKTX
$3.04B
| $5M | 1.38% | +300,000 | New | +$5M |
|
8
Chart Industries
GTLS
$8.96B
| $4.57M | 1.26% | 36,468 -63,532 | -64% | -$7.97M |
|
9
Royal Caribbean
RCL
$98.7B
| $4.24M | 1.17% | +65,000 | New | +$4.24M |
|
10
AerCap
AER
$22B
| $4.22M | 1.16% | +75,000 | New | +$4.22M |
|
11
Structure Therapeutics
GPCR
$1.11B
| $4.04M | 1.12% | +170,000 | New | +$4.04M |
|
12
argenx
ARGX
$43.6B
| $3.73M | 1.03% | +10,000 | New | +$3.73M |
|
13
Roivant Sciences
ROIV
$8.15B
| $3.69M | 1.02% | 500,000 +30,000 | +6% | +$221K |
|
14
Biohaven
BHVN
$1.63B
| $3.42M | 0.94% | 250,000 +50,000 | +25% | +$683K |
|
15
Atlas Energy Solutions
AESI
$1.45B
| $3.41M | 0.94% | +200,000 | New | +$3.41M |
|
16
Biomea Fusion
BMEA
$116M
| $2.79M | 0.77% | +90,000 | New | +$2.79M |
|
|
SLGC
17
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $2.52M | 0.7% | 989,861 -10,139 | -1% | -$25.9K |
|
|
AVDL
18
Avadel Pharmaceuticals
AVDL
$1.43B
| $2.52M | 0.7% | +275,000 | New | +$2.52M |
|
19
Bumble
BMBL
$642M
| $2.44M | 0.67% | +125,000 | New | +$2.44M |
|
20
AN2 Therapeutics
ANTX
$30.1M
| $2.44M | 0.67% | 247,467 -202,533 | -45% | -$2M |
|
21
Laureate Education
LAUR
$4.05B
| $2.44M | 0.67% | 207,323 -490,981 | -70% | -$5.77M |
|
22
Evolus
EOLS
$494M
| $2.41M | 0.67% | +285,000 | New | +$2.41M |
|
|
ESMT
23
DELISTED
EngageSmart, Inc.
ESMT
| $2.02M | 0.56% | +105,000 | New | +$2.02M |
|
24
Mineralys Therapeutics
MLYS
$1.03B
| $1.72M | 0.48% | +110,000 | New | +$1.72M |
|
25
Travere Therapeutics
TVTX
$1.56B
| $1.69M | 0.47% | +75,000 | New | +$1.69M |
|